| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Citrulline | 23 | 2021 | 108 | 9.800 |
Why?
|
| Arginine | 26 | 2021 | 500 | 7.370 |
Why?
|
| Glutamine | 12 | 2018 | 299 | 3.300 |
Why?
|
| Urea | 12 | 2018 | 290 | 2.220 |
Why?
|
| Ornithine | 6 | 2012 | 40 | 1.980 |
Why?
|
| Intestinal Mucosa | 9 | 2020 | 1081 | 1.900 |
Why?
|
| Arginase | 4 | 2020 | 48 | 1.870 |
Why?
|
| Nitrogen | 10 | 2017 | 162 | 1.740 |
Why?
|
| Nutritional Requirements | 4 | 2017 | 185 | 1.570 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 7 | 2018 | 34 | 1.560 |
Why?
|
| Gastrointestinal Tract | 4 | 2018 | 324 | 1.520 |
Why?
|
| Nitric Oxide | 8 | 2018 | 644 | 1.400 |
Why?
|
| Hydrolases | 3 | 2021 | 123 | 1.380 |
Why?
|
| Swine | 11 | 2021 | 1541 | 1.360 |
Why?
|
| Nitrogen Isotopes | 7 | 2018 | 60 | 1.290 |
Why?
|
| Ornithine Carbamoyltransferase | 5 | 2018 | 22 | 1.260 |
Why?
|
| Kidney | 8 | 2020 | 2146 | 1.210 |
Why?
|
| Phenylbutyrates | 4 | 2017 | 59 | 1.180 |
Why?
|
| Polyethylene Glycols | 3 | 2021 | 615 | 1.110 |
Why?
|
| Amino Acids | 6 | 2020 | 728 | 1.080 |
Why?
|
| Animals, Newborn | 10 | 2020 | 1338 | 1.060 |
Why?
|
| Diet | 6 | 2017 | 1440 | 0.850 |
Why?
|
| Animals | 55 | 2022 | 59536 | 0.820 |
Why?
|
| Cattle | 5 | 2007 | 783 | 0.810 |
Why?
|
| Mice, Inbred ICR | 7 | 2018 | 239 | 0.800 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2020 | 703 | 0.740 |
Why?
|
| Duodenum | 1 | 2020 | 149 | 0.710 |
Why?
|
| Jejunum | 1 | 2020 | 216 | 0.700 |
Why?
|
| Glycine | 2 | 2020 | 289 | 0.690 |
Why?
|
| Carbon Isotopes | 6 | 2017 | 333 | 0.640 |
Why?
|
| Endotoxins | 1 | 2018 | 96 | 0.640 |
Why?
|
| Proline | 4 | 2012 | 130 | 0.630 |
Why?
|
| Urea Cycle Disorders, Inborn | 2 | 2020 | 80 | 0.620 |
Why?
|
| Dietary Supplements | 3 | 2017 | 558 | 0.600 |
Why?
|
| Fetal Development | 1 | 2018 | 120 | 0.590 |
Why?
|
| Growth | 1 | 2017 | 117 | 0.590 |
Why?
|
| Mice, Inbred C57BL | 13 | 2020 | 6942 | 0.580 |
Why?
|
| Mice | 32 | 2022 | 34495 | 0.570 |
Why?
|
| Benzoates | 1 | 2017 | 136 | 0.570 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2020 | 223 | 0.570 |
Why?
|
| Dietary Proteins | 3 | 2014 | 241 | 0.550 |
Why?
|
| Hyperammonemia | 2 | 2006 | 68 | 0.540 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 1498 | 0.510 |
Why?
|
| Biological Availability | 4 | 2021 | 214 | 0.510 |
Why?
|
| Sex Characteristics | 1 | 2017 | 417 | 0.500 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2014 | 101 | 0.490 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2014 | 52 | 0.490 |
Why?
|
| Aging | 2 | 2019 | 1582 | 0.480 |
Why?
|
| Intestines | 1 | 2018 | 686 | 0.470 |
Why?
|
| Argininosuccinate Lyase | 4 | 2020 | 66 | 0.460 |
Why?
|
| Sus scrofa | 3 | 2020 | 169 | 0.440 |
Why?
|
| Muscle Proteins | 2 | 2015 | 549 | 0.440 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 46 | 0.440 |
Why?
|
| Intestine, Small | 4 | 2019 | 499 | 0.430 |
Why?
|
| Muscle, Skeletal | 3 | 2015 | 1270 | 0.420 |
Why?
|
| Membrane Transport Proteins | 2 | 2004 | 244 | 0.420 |
Why?
|
| Male | 36 | 2021 | 123000 | 0.410 |
Why?
|
| Rumen | 4 | 2005 | 12 | 0.410 |
Why?
|
| Ammonia | 6 | 2010 | 88 | 0.410 |
Why?
|
| Gestational Age | 2 | 2015 | 1069 | 0.410 |
Why?
|
| Digestion | 3 | 2009 | 55 | 0.410 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2011 | 94 | 0.400 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 321 | 0.390 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 81 | 0.390 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2018 | 336 | 0.370 |
Why?
|
| Random Allocation | 5 | 2017 | 703 | 0.360 |
Why?
|
| Dipeptides | 3 | 2018 | 91 | 0.350 |
Why?
|
| Mice, Mutant Strains | 4 | 2018 | 634 | 0.340 |
Why?
|
| Liver | 7 | 2018 | 2961 | 0.340 |
Why?
|
| Parenteral Nutrition | 4 | 2020 | 207 | 0.340 |
Why?
|
| Isotope Labeling | 3 | 2018 | 142 | 0.340 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 84 | 0.330 |
Why?
|
| Argininosuccinic Aciduria | 4 | 2012 | 52 | 0.330 |
Why?
|
| Models, Animal | 3 | 2020 | 664 | 0.310 |
Why?
|
| Glutaredoxins | 2 | 2019 | 43 | 0.310 |
Why?
|
| Citric Acid Cycle | 3 | 2017 | 86 | 0.300 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 702 | 0.300 |
Why?
|
| Kinetics | 4 | 2021 | 2049 | 0.300 |
Why?
|
| Insulin Resistance | 3 | 2022 | 731 | 0.300 |
Why?
|
| Models, Biological | 5 | 2014 | 3254 | 0.300 |
Why?
|
| Mice, Knockout | 8 | 2020 | 5710 | 0.290 |
Why?
|
| Feces | 3 | 2005 | 770 | 0.290 |
Why?
|
| Weaning | 2 | 2017 | 45 | 0.280 |
Why?
|
| Flow Injection Analysis | 1 | 2006 | 3 | 0.280 |
Why?
|
| Phenylalanine | 4 | 2010 | 142 | 0.280 |
Why?
|
| Female | 30 | 2022 | 141928 | 0.280 |
Why?
|
| Infusions, Intravenous | 3 | 2018 | 1382 | 0.270 |
Why?
|
| Deuterium | 3 | 2017 | 111 | 0.270 |
Why?
|
| Urinalysis | 1 | 2006 | 84 | 0.260 |
Why?
|
| Mutation | 3 | 2018 | 15179 | 0.260 |
Why?
|
| Glycolysis | 3 | 2017 | 519 | 0.250 |
Why?
|
| Liver Diseases | 3 | 2020 | 574 | 0.240 |
Why?
|
| Sheep | 1 | 2004 | 258 | 0.230 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 558 | 0.230 |
Why?
|
| Exosomes | 2 | 2017 | 253 | 0.230 |
Why?
|
| Energy Metabolism | 3 | 2014 | 992 | 0.220 |
Why?
|
| Proteins | 1 | 2011 | 1963 | 0.220 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 7222 | 0.210 |
Why?
|
| Short Bowel Syndrome | 2 | 2020 | 60 | 0.210 |
Why?
|
| Carrier Proteins | 2 | 2017 | 2022 | 0.200 |
Why?
|
| Tumor Microenvironment | 3 | 2017 | 2864 | 0.200 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2022 | 75 | 0.200 |
Why?
|
| Glucose | 4 | 2022 | 1248 | 0.190 |
Why?
|
| Argininosuccinate Synthase | 2 | 2018 | 54 | 0.180 |
Why?
|
| Liver Glycogen | 1 | 2020 | 31 | 0.180 |
Why?
|
| Lactation | 2 | 2016 | 210 | 0.180 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2019 | 53 | 0.170 |
Why?
|
| Tissue Distribution | 1 | 2021 | 875 | 0.170 |
Why?
|
| Animal Feed | 2 | 2017 | 81 | 0.170 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2020 | 182 | 0.160 |
Why?
|
| Vasomotor System | 1 | 2018 | 29 | 0.160 |
Why?
|
| Colitis | 2 | 2012 | 340 | 0.160 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2010 | 93 | 0.160 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 114 | 0.160 |
Why?
|
| Genotype | 3 | 2020 | 4109 | 0.160 |
Why?
|
| Cardiomegaly | 1 | 2019 | 195 | 0.160 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 1073 | 0.160 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 987 | 0.150 |
Why?
|
| Animals, Domestic | 1 | 2017 | 40 | 0.150 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2016 | 15 | 0.150 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 187 | 0.150 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 241 | 0.140 |
Why?
|
| Enteral Nutrition | 1 | 2018 | 316 | 0.140 |
Why?
|
| Gene Editing | 1 | 2018 | 216 | 0.140 |
Why?
|
| Species Specificity | 1 | 2017 | 777 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 488 | 0.130 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2015 | 17 | 0.130 |
Why?
|
| Thinness | 1 | 2016 | 82 | 0.130 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 323 | 0.130 |
Why?
|
| Diet, Protein-Restricted | 1 | 2016 | 82 | 0.130 |
Why?
|
| Sex Factors | 2 | 2017 | 2139 | 0.130 |
Why?
|
| Vitamin E | 1 | 2015 | 136 | 0.120 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2015 | 70 | 0.120 |
Why?
|
| Ligation | 1 | 2014 | 193 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2019 | 5637 | 0.120 |
Why?
|
| Cell Communication | 1 | 2017 | 509 | 0.120 |
Why?
|
| Blood Urea Nitrogen | 2 | 2004 | 95 | 0.120 |
Why?
|
| Pregnancy | 4 | 2016 | 7573 | 0.120 |
Why?
|
| Fibroblasts | 3 | 2016 | 1682 | 0.110 |
Why?
|
| Regression Analysis | 2 | 2007 | 1546 | 0.110 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2014 | 69 | 0.110 |
Why?
|
| Radioactive Tracers | 1 | 2012 | 30 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 268 | 0.110 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 533 | 0.110 |
Why?
|
| Thionucleosides | 1 | 2012 | 12 | 0.110 |
Why?
|
| Epithelial Cells | 2 | 2016 | 1818 | 0.110 |
Why?
|
| Premature Birth | 1 | 2017 | 407 | 0.110 |
Why?
|
| Glycogenolysis | 1 | 2012 | 11 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 2063 | 0.110 |
Why?
|
| Cell Proliferation | 5 | 2019 | 7226 | 0.100 |
Why?
|
| Ghrelin | 1 | 2012 | 79 | 0.100 |
Why?
|
| Dansyl Compounds | 1 | 2011 | 7 | 0.100 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2011 | 5 | 0.100 |
Why?
|
| Gluconeogenesis | 1 | 2012 | 121 | 0.100 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2010 | 15 | 0.100 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2011 | 53 | 0.100 |
Why?
|
| Food Deprivation | 2 | 2012 | 47 | 0.100 |
Why?
|
| Homocysteine | 1 | 2011 | 138 | 0.100 |
Why?
|
| Methionine | 1 | 2011 | 159 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 261 | 0.090 |
Why?
|
| Adenosine | 1 | 2012 | 289 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 889 | 0.090 |
Why?
|
| Humans | 21 | 2020 | 261506 | 0.090 |
Why?
|
| Neoplasms | 4 | 2017 | 15193 | 0.090 |
Why?
|
| Nephrectomy | 1 | 2014 | 779 | 0.090 |
Why?
|
| Injections, Intravenous | 2 | 2007 | 573 | 0.090 |
Why?
|
| alpha-Glucosidases | 1 | 2009 | 55 | 0.080 |
Why?
|
| Starch | 1 | 2009 | 47 | 0.080 |
Why?
|
| Phenotype | 3 | 2018 | 6295 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 368 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 521 | 0.080 |
Why?
|
| Ovarian Neoplasms | 2 | 2014 | 4638 | 0.080 |
Why?
|
| Rats | 1 | 2017 | 6086 | 0.080 |
Why?
|
| Adult | 7 | 2017 | 77950 | 0.080 |
Why?
|
| Germ-Free Life | 1 | 2007 | 69 | 0.080 |
Why?
|
| Mitochondria | 1 | 2014 | 1282 | 0.070 |
Why?
|
| Alanine | 1 | 2007 | 240 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 521 | 0.070 |
Why?
|
| Mountaineering | 1 | 2006 | 3 | 0.070 |
Why?
|
| Altitude | 1 | 2006 | 39 | 0.070 |
Why?
|
| Alanine Transaminase | 2 | 2020 | 227 | 0.070 |
Why?
|
| Maze Learning | 1 | 2006 | 132 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 1538 | 0.070 |
Why?
|
| Dietary Fiber | 2 | 2003 | 123 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 4053 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1362 | 0.070 |
Why?
|
| Middle Aged | 5 | 2017 | 86204 | 0.070 |
Why?
|
| Environmental Pollution | 1 | 2005 | 19 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 4938 | 0.060 |
Why?
|
| Insulin | 3 | 2022 | 1454 | 0.060 |
Why?
|
| Heart Failure | 1 | 2019 | 2516 | 0.060 |
Why?
|
| Fasting | 2 | 2022 | 349 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 2 | 2016 | 153 | 0.060 |
Why?
|
| Enzymes | 1 | 2004 | 64 | 0.060 |
Why?
|
| Genetic Therapy | 1 | 2012 | 1616 | 0.060 |
Why?
|
| Urease | 1 | 2004 | 60 | 0.060 |
Why?
|
| Attention | 1 | 2006 | 281 | 0.060 |
Why?
|
| Inflammation | 3 | 2012 | 2522 | 0.060 |
Why?
|
| Social Behavior | 1 | 2006 | 306 | 0.060 |
Why?
|
| Homeostasis | 1 | 2009 | 950 | 0.060 |
Why?
|
| Bacteria | 1 | 2007 | 611 | 0.060 |
Why?
|
| Memory | 1 | 2006 | 429 | 0.050 |
Why?
|
| Infant, Premature | 2 | 2020 | 787 | 0.050 |
Why?
|
| Organ Size | 1 | 2004 | 690 | 0.050 |
Why?
|
| Energy Intake | 1 | 2005 | 515 | 0.050 |
Why?
|
| Dextran Sulfate | 2 | 2012 | 72 | 0.050 |
Why?
|
| Milk | 1 | 2002 | 120 | 0.050 |
Why?
|
| Creatinine | 1 | 2004 | 531 | 0.050 |
Why?
|
| Weight Loss | 1 | 2006 | 627 | 0.050 |
Why?
|
| Peroxidase | 2 | 2012 | 132 | 0.050 |
Why?
|
| Adolescent | 5 | 2012 | 31252 | 0.050 |
Why?
|
| Glutathione | 2 | 2014 | 368 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2017 | 14551 | 0.050 |
Why?
|
| Enteroendocrine Cells | 1 | 2019 | 24 | 0.040 |
Why?
|
| Young Adult | 3 | 2012 | 21445 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2014 | 2307 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2018 | 171 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 4971 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 360 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2019 | 284 | 0.040 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2016 | 46 | 0.040 |
Why?
|
| Cytokines | 1 | 2006 | 2809 | 0.040 |
Why?
|
| Pregnancy, Animal | 1 | 2016 | 92 | 0.040 |
Why?
|
| Plasmids | 1 | 2018 | 837 | 0.040 |
Why?
|
| Milk Proteins | 1 | 2016 | 116 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2018 | 351 | 0.030 |
Why?
|
| Nucleotides | 1 | 2016 | 164 | 0.030 |
Why?
|
| Fermentation | 1 | 2016 | 60 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2016 | 29 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2016 | 119 | 0.030 |
Why?
|
| Carbon | 1 | 2016 | 149 | 0.030 |
Why?
|
| Child | 3 | 2012 | 29154 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 6009 | 0.030 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2016 | 107 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 5159 | 0.030 |
Why?
|
| Phytosterols | 1 | 2015 | 31 | 0.030 |
Why?
|
| Soybean Oil | 1 | 2015 | 66 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 562 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 253 | 0.030 |
Why?
|
| Fish Oils | 1 | 2015 | 88 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1945 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2020 | 8223 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2016 | 6150 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1819 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2016 | 576 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2014 | 44 | 0.030 |
Why?
|
| NADP | 1 | 2014 | 96 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2016 | 305 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2022 | 2203 | 0.030 |
Why?
|
| Metabolome | 1 | 2016 | 344 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 764 | 0.030 |
Why?
|
| Gene Expression | 2 | 2012 | 3570 | 0.030 |
Why?
|
| Argininosuccinic Acid | 1 | 2012 | 7 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 1217 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 825 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1129 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2012 | 173 | 0.030 |
Why?
|
| Receptors, Ghrelin | 1 | 2012 | 35 | 0.030 |
Why?
|
| Nitrites | 1 | 2011 | 61 | 0.030 |
Why?
|
| Pyridoxal Phosphate | 1 | 2011 | 15 | 0.030 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2011 | 18 | 0.030 |
Why?
|
| Methylmalonic Acid | 1 | 2011 | 15 | 0.030 |
Why?
|
| Placebos | 1 | 2012 | 437 | 0.030 |
Why?
|
| Eating | 1 | 2014 | 421 | 0.030 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2010 | 12 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2012 | 16273 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 392 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 460 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 1392 | 0.020 |
Why?
|
| Keto Acids | 1 | 2010 | 59 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2016 | 11965 | 0.020 |
Why?
|
| Body Composition | 1 | 2014 | 595 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 548 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 314 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2016 | 769 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 3536 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 289 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2016 | 2450 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2016 | 1549 | 0.020 |
Why?
|
| Sucrase | 1 | 2009 | 26 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2016 | 4307 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1077 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 478 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2014 | 2084 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2009 | 271 | 0.020 |
Why?
|
| Electron Transport | 1 | 2007 | 79 | 0.020 |
Why?
|
| Metabolomics | 1 | 2011 | 478 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 363 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2007 | 62 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2007 | 108 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 2315 | 0.020 |
Why?
|
| Methylhistidines | 1 | 2006 | 10 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2007 | 218 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 2588 | 0.020 |
Why?
|
| Alkalosis | 1 | 2006 | 28 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2006 | 77 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 3472 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 1293 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2006 | 119 | 0.020 |
Why?
|
| Thyroxine | 1 | 2006 | 116 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 7548 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 2216 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2011 | 1048 | 0.020 |
Why?
|
| Aged | 1 | 2011 | 70117 | 0.020 |
Why?
|
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 1 | 2004 | 5 | 0.020 |
Why?
|
| Hyperargininemia | 1 | 2004 | 13 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2006 | 388 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 5377 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 2483 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 5114 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2006 | 288 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2004 | 108 | 0.010 |
Why?
|
| Hypoxia | 1 | 2006 | 443 | 0.010 |
Why?
|
| Carrier State | 1 | 2003 | 90 | 0.010 |
Why?
|
| Biomarkers | 1 | 2015 | 5047 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2006 | 630 | 0.010 |
Why?
|
| Gene Regulatory Networks | 1 | 2007 | 677 | 0.010 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2002 | 59 | 0.010 |
Why?
|
| Hypertension | 1 | 2012 | 1503 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2010 | 4804 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 614 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6207 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 2508 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 4320 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 1544 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 7702 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 3154 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 8873 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 32848 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 4078 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 21713 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 6100 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 14889 | 0.010 |
Why?
|